A multivalent biparatopic EGFR-targeting nanobody drug conjugate displays potent anticancer activity in solid tumor models
Jiansheng Fan, Xinlei Zhuang, Xiaoyue Yang, Yingchun Xu, Zhan Zhou, Liqiang Pan, Shuqing Chen
Topics & Concepts
ConjugateDrugAnticancer drugPharmacologyCancer researchChemistrySolid tumorAntibody-drug conjugateMedicineComputational biologyAntibodyMonoclonal antibodyCancerImmunologyBiologyInternal medicineMathematical analysisMathematicsMonoclonal and Polyclonal Antibodies ResearchLung Cancer Research StudiesRadiopharmaceutical Chemistry and Applications